Prostate Cancer - Results from #20800

Prior-cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate-cancer-specific and all-cause mortality - Abstract April 18, 2014

Obligatory information that a patient diagnosed of prostate cancer and candidate for an active surveillance protocol must know - Abstract April 18, 2014

Tissue biomarkers for prognosis of prostate cancer: A systematic review and meta-analysis - Abstract April 18, 2014

Focal radiotherapy as focal therapy of prostate cancer - Abstract April 18, 2014

What is still needed to make focal therapy an accepted segment of standard therapy? - Abstract April 18, 2014

Living with untreated prostate cancer: Predictors of quality of life - Abstract April 17, 2014

Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the Zometa European Study (ZEUS) - Abstract April 17, 2014

How to select the right patients for focal therapy of prostate cancer? - Abstract April 17, 2014

The influence of prostate volume on cancer detection in the Chinese population - Abstract April 17, 2014

Transrectal Doppler ultrasound during prostate biopsy: Clinical utility and limitations - Abstract April 17, 2014

Advantages and limitations of navigation-based multicriteria optimization (MCO) for localized prostate cancer IMRT planning - Abstract April 17, 2014

Predictors of unfavorable disease after radical prostatectomy in patients who are low risk by D'Amico criteria: Role of multiparametric MRI - Abstract April 17, 2014

Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer - Abstract April 17, 2014

Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer - Abstract April 17, 2014

Seminal vesicle intraepithelial neoplasia versus basal cell hyperplasia in a seminal vesicle - Abstract April 17, 2014

Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: Results from a phase 2 nonrandomized expansion cohort - Abstract April 17, 2014

NIH-funded study shows increased survival in men with metastatic prostate cancer who receive chemotherapy when starting hormone therapy April 17, 2014

Implementing newer agents for the management of castrate-resistant prostate cancer: What is known and what is needed? - Abstract April 15, 2014

Laser ablation as focal therapy for prostate cancer - Abstract April 15, 2014

A modified point count method as a practical approach to assess the tumor volume and the percent gland involvement by prostate carcinoma - Abstract April 15, 2014

Page 1041 of 1437